Warning letter
Smruthi Organics Limited: warning letter of Mar 6, 2014
FDA warning letter 416931 · Center for Drug Evaluation and Research
Key facts
| Reference number | 416931 |
|---|---|
| Company | Smruthi Organics Limited |
| Subject | CGMP/Finished Pharmaceuticals/Adulterated/HPLC |
| Issue date | Mar 6, 2014 |
| Posted date | Mar 23, 2014 |
| Issuing office | Center for Drug Evaluation and Research |
| Product type | Drugs |
| Inspection city | Solapur District, Maharashtra |
| Inspection start date | Oct 15, 2013 |
| Letter on fda.gov | web.archive.org |
At a glance
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: